Molecular markers demonstrate diagnostic and prognostic value in the evaluation of myelodysplastic syndromes in cytopenia patients
分子标志物在评估伴有血细胞减少症的骨髓增生异常综合征患者中显示出诊断和预后价值。
期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-022-00612-w
He, Rong; Chiou, Jonathan; Chiou, Allison; Chen, Dong; Chen, Constance P; Spethman, Caroline; Bessonen, Kurt R; Oliveira, Jennifer L; Nguyen, Phuong L; Reichard, Kaaren K; Hoyer, James D; Althoff, Simon D; Roh, Dana J; Miller, Mechelle A; Yuan, Ji; Olteanu, Horatiu; Begna, Kebede; Tefferi, Ayalew; Alkhateeb, Hassan; Patnaik, Mrinal M; Litzow, Mark R; Al-Kali, Aref; Viswanatha, David S
